Search results for: mosquito borne virus

Showing 1 - 10 of 25 results

9 March 2022

Studies reveal new mechanisms of arthritis caused by mosquito-borne viruses 

Some successful rheumatoid arthritis therapies may help us better understand how to treat people with mosquito-borne viral diseases.

Read More
3 February 2016
Institute for Glycomics and the Eskitis Institute for Drug Discovery will explore the effects Zika virus has on neurological cells.

Here’s why we don’t have a vaccine for Zika (and other mosquito-borne viruses)

By Suresh Mahalingam, Principal Research Leader, Institute for Glycomics As Zika fear rises, especially in the wake of the World...

Read More
27 October 2023
Test tubes in a tray

Key muscle protein may unlock the mystery of chronic mosquito-borne viral illness

Underlying evolutionary dynamics could play a key role in the replication and progress of the chikungunya virus, a mosquito-borne viral disease.

Read More
27 November 2020

Virus researcher recognised at Gold Coast Women in Business Awards

Dr Lara Herrero, research leader at Griffith University’s Institute for Glycomics, has been honoured with the Creating Change Award at...

Read More
10 December 2019

Study to develop drugs for chronic mosquito-borne viral diseases

A new Griffith University study aims to develop drugs to treat alphavirus infection such as Ross River, Chikungunya, O’nyong’nyong and...

Read More
27 June 2019

Research Group leads fight against Zika and Ross River viruses

The threat of mosquito-borne outbreaks of emerging viruses will be tackled by the newly-established Research Group for Emerging Viruses, Inflammation and Therapeutics.

Read More
25 February 2019
Read More
16 January 2019
Read More
29 August 2017

Drug breakthrough for mozzie virus outbreaks

Scientists have discovered a way that could help treat severe inflammation from an infectious mosquito-borne disease during outbreaks. A team...

Read More
7 September 2016
Dr Lara Herrero

Ross River virus battle breakthrough

Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited has uncovered a potential new therapeutic treatment in the global battle against mosquito-borne alphavirus infections, including the debilitating Ross River Virus and Chikungunya Virus.

Read More